Power Life High Impact Plant Protein - recalled due to undeclared milk, USA

1 year ago •source www.fda.gov

Recall notice

United States

Power Life Nutrition of Woodland Hills, CA is voluntarily recalling a limited amount of its High Impact Plant Protein due to a labeling error. For a brief period during the manufacturing process, jars containing High Impact Whey Protein were mislabeled as High Impact Plant Protein. The mislabeled product is safe to consume for consumers who ordered High Impact Whey Protein, but it does not contain an allergen declaration for the milk allergen in the product. People who have allergies to milk run the risk of serious or life-threatening allergic reaction if they consume these products. The recalled units of High Impact Plant Protein were shipped to customers who purchased High Impact Whey Protein from Power Life Nutrition’s website between October 18, 2022 through November 30, 2022. No serious adverse reactions have been reported to date in connection with this problem.

The product comes in a 50 ounce jar marked with lot #0914922 on the bottom.

The recall was initiated after it was discovered that a limited quantity of units of High Impact Whey Protein incorrectly contained the label for High Impact Plant Protein. Subsequent investigation indicates the problem was caused by an error in the manufacturer’s packaging process manufacturer.

No other lot numbers of High Impact Whey Protein or Plant Protein are impacted by this voluntary recall.

Consumers who have received units of High Impact Plant Protein marked lot #0914922 are urged to contact Power Life Nutrition to receive a prepaid return shipping label and free replacement product.

In case you experienced harm from allergens or undeclared ingredients, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: THGH Partners LLC
Brand name: Power Life
Product recalled: High Impact Plant Protein
Reason of the recall: Undeclared Milk
FDA Recall date: December 15, 2022

Source: www.fda.gov

#allergicreaction #us #allergen #sub #milk

Recent Interesting Reports

X
Received a bottle that I never ordered, charged our card, wife ordered a mug from Starbucks, and that is when they charged our card twice. My wife thought she was ordering a cup from a Starbucks email, but instead they charged our card twice for almost 200 dollars

Im in Columbus, OH, USA

#onlineshopping #scam #onlinescam #delivery #tampa #florida #us

W

Feathers Fottys is an absolute scam, Michigan, USA

1 week ago •reported by user-whnhc378

Feathers Fottys is an absolute scam. The product is cheaply made with no instructions at all. Ordered the neck beauty device. It’s a joke but I am reporting their scam.

The promo on Facebook was made to look so promising for turkey neck issues and facial wrinkles. … See More
I ordered the product which took forever to get here. The product came in a nondescript I’ve box with absolutely no instructions on how to use it and no return instructions. There isn’t even contact  info.
See Less

#falseadvertising #michigan #us

F

Ketogenesis scam, Las Vegas, Nevada, USA

1 week ago •reported by user-ffhdg745

I reporting a scam. Order 5 Btles of red or multi color gummies but received some yellow gummies. I had a phone number which I called they refunded me $50 which was not one of my questions. This product did not due anything it said it was … See More
going to do. Rec

Found phone # 18443789375. The company on my billing account was food and specialty store. Wouldn’t give address. Post office will not mail to p.o. #. But company will give you a RMA# to use. Spread this info out there. Their spam scum. Ketogenesis Keto+ACV PO box81827 Las Vegas Nevada 89180-1827

Called bank and blocked this.
See Less

#scam #onlineshopping #ketogummiesscam #onlinescam #delivery #lasvegas #nevada #us

AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product found during stability testing at a 3rd party lab. Atovaquone Oral Suspension, USP was distributed between 03/18/2024 through 03/21/2024 … See More
Nationwide to Wholesalers. To date, AvKARE has not received any reports of adverse events related to this recall.

Risk Statement: In the population most at risk, immunocompromised population, there is a reasonable probability that microbial contamination of Atovaquone Oral Suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.

Atovaquone Oral Suspension, USP is indicated for prevention and treatment of Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other medicines, such as trimethoprim-sulfamethoxazole.

The product is packaged in a carton. The identified NDC # associated with the product is 50268-086-12, UPC # 5026808612 and the affected lot# is AW0221A with an expiration date of 08/2025.

AvKARE, LLC is notifying its distributors and wholesale customers by mailings and email communications method and is arranging for returns of all recalled Atovaquone Oral Suspension, USP. Wholesalers who have Atovaquone Oral Suspension, USP 750mg/5mL, which are being recalled, should examine their inventory and cease dispensing, return any of the impacted lots to AvKARE, LLC. Consumers that have product which is being recalled should stop using the product and return it to place of purchase.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.  

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: AvKARE, LLC
Brand name: AVpak
Product recalled: Atovaquone Oral Suspension, USP 750mg/5mL
Reason of the recall: Potential Bacillus cereus contamination
FDA Recall date: April 01, 2024

Source: www.fda.gov
See Less

#drugs #us

Create a Report

Please provide report title
Please provide location
Please provide details

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by

Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery
Last 30 days